You are using an older browser version. Please use a supported version for the best MSN experience.

Sage Therapeutics slumps, Biogen bounces

CNBC's Meg Tirrell reports on shares of Sage Therapeutics slumping after a disappointing drug trial. Also, Biogen's up-and-down day.
image beaconimage beaconimage beacon